Innovations Involving Use of Quantum Dots in Life Science, Advanced Drug Discovery Platforms, and AAV-vector Manufacturing

Share this:
Published: 9 Nov 2018

The Life Science, Health & Wellness TOE encompasees recent advances in quantum dots, diagnostics, treatment and drug discovery, and platforms that have the potential to transform the future of healthcare. The 12 disruptive innovations profiled in this publication include VIVODOTS™, Tetrapod quantum dots, Qdot® nanocrystals, QC/AI-driven platform, HSC therapy, In silico drug discovery, pharmacogenetics report, PSVT nasal therapy, AAV CDMO, LDL-C drug, neuroimaging, and HIV immunotherapy. The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Quantum dots, drug discovery, neuroimaging, stem cells, immunotherapy, in-silico drug discovery, pharmacogenetics, nasal therapy, nanocrystals, artificial intelligence, HIV


Features of this research


Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..